TY  - JOUR
AU  - Kayser, Sabine
AU  - Benner, A.
AU  - Thiede, C.
AU  - Martens, U.
AU  - Huber, J.
AU  - Stadtherr, P.
AU  - Janssen, J. W. G.
AU  - Röllig, C.
AU  - Uppenkamp, M. J.
AU  - Bochtler, T.
AU  - Hegenbart, U.
AU  - Ehninger, G.
AU  - Ho, A. D.
AU  - Dreger, P.
AU  - Krämer, Alwin
TI  - Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
JO  - Blood cancer journal
VL  - 6
IS  - 7
SN  - 2044-5385
CY  - London [u.a.]
PB  - Nature Publishing Group
M1  - DKFZ-2017-04890
SP  - e449 -
PY  - 2016
AB  - The objective was to evaluate the prognostic impact of pre-transplant minimal residual disease (MRD) as determined by real-time quantitative polymerase chain reaction in 67 adult NPM1-mutated acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). Twenty-eight of the 67 patients had a FLT3-ITD (42
LB  - PUB:(DE-HGF)16
C6  - pmid:27471865
C2  - pmc:PMC5030374
DO  - DOI:10.1038/bcj.2016.46
UR  - https://inrepo02.dkfz.de/record/128877
ER  -